Filing Details
- Accession Number:
- 0001140361-15-010833
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-06 19:19:51
- Reporting Period:
- 2015-03-04
- Filing Date:
- 2015-03-06
- Accepted Time:
- 2015-03-06 19:19:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1416792 | Relypsa Inc | RLYP | Pharmaceutical Preparations (2834) | 260893742 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591465 | Claire Lockey | C/O Relypsa, Inc. 100 Cardinal Way Redwood City CA 94063 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-04 | 9,052 | $4.65 | 14,552 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-03-04 | 948 | $3.79 | 15,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-04 | 10,000 | $40.00 | 5,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-03-04 | 9,052 | $0.00 | 9,052 | $4.65 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-03-04 | 948 | $0.00 | 948 | $3.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 215 | 2020-09-28 | No | 4 | M | Direct | |
| 25,214 | 2020-05-24 | No | 4 | M | Direct |
Footnotes
- Includes 5,500 restricted stock units.
- The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- 100% of the shares subject to the option are fully vested and exercisable.
Billionaire Hedge Funds
